You are here

Therapeutic Advances in Reproductive Health

eISSN: 26334941 | ISSN: 26334941 | Current volume: 17 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Launched in 2008
  • Gold open access journal – all articles are made freely available online immediately upon publication
  • Rigorous peer review
  • Listed in PubMed and indexed in Web of Science and Emerging Sources Citation Index (ESCI)

Therapeutic Advances in Reproductive Health is a peer-reviewed open access journal which focuses on all aspects of male and female human reproductive health and medicine, spanning physical, psychological and social issues. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

This journal flipped to open access on November 15, 2017.

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Reproductive Health promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the reproductive health community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC for this journal is currently $2000 USD. The article processing charge for Plain Language Summary is $4500 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Please direct any pre-submission enquiries (or any other queries) to the Managing Editor Lauren Kelly on


Therapeutic Advances in Reproductive Health delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the field of reproductive health and medicine. The journal is aimed at an international audience of clinicians and researchers, providing an online forum for rapid dissemination of recent research and perspectives. Subjects covered include (but are not limited to):


• Fertility and Sterility

• Infertility and Assisted Reproductive Technology (e.g., in vitro fertilisation [IVF], intracytoplasmic sperm injection [ICSI], ovulation induction, artificial insemination, donor conception, gamete intrafallopian transfer, preimplantation genetic testing, surrogacy)

• Fertility preservation

• Paediatric and Adolescent Gynaecology

• Menstruation and pre-menstrual tension

• Contraception

• Pregnancy (issues pertaining to the mother and to embryonic/foetal development)

• Childbirth and Post-natal care

• Post-partum depression

• Menopause and Hormone replacement therapy (HRT)

• Women's Health

• Infections and disease

• Gynecologic oncology/Reproductive cancers

• Obstetrics/Gynaecology, including Ob/Gyn Surgery

• Andrology

• Pelvic floor problems

• Pelvic inflammatory disease (PID)

• Endometriosis

• Polycystic ovary syndrome (PCOS)

• Environmental impacts on reproduction


The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.


Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, post-marketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment.

The journal adheres to a single-blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.



Zeev Blumenfeld MD Rambam Medical Center, Israel
Associate Editors
Giuliano Bedoschi, MD, PhD University of São Paulo, São Paulo, Brazil
Rossella Cannarella, MD, PhD University of Catania, Catania, Italy
Kuniaki Ota MD, PhD Fukushima Medical University, Okayama, Japan
Ioannis Tsakiridis MD, PhD Third Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece
Managing Editor
Lauren Kelly SAGE Publishing, London, UK
Editorial Board Member
Luca Arecco, MD IRCCS San Martino Policlinico Hospital, University of Genova, Genova, Italy
Yaakov Bentov MD, MSc Faculty of Health Sciences, McMaster University, Ontario, Canada
Petra M. Casey MD Mayo Clinic, Rochester, Minnesota, USA
Camil Castelo-Branco, PhD University of Barcelona, Hospital Clínic, Barcelona, Spain
Andrea Crafa, MD University of Catania, Catania, Italy
Graeme Dennerstein MBBS, FRCOG, FRANZCOG Western Health, Melbourne, Victoria, Australia
Jonathan Edwards, BMSc, MBBS, MPhil The Medical Research Foundation of Trinidad and Tobago, Port of Spain, Trinidad and Tobago
David Ehrmann MD Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, IL, USA
Ellen Goossens PhD Department of Reproduction, Genetics and Regenerative Medicine, Vrije University Brussels, Brussels, Belgium
Roy Homburg MB.BS, FRCOG Homerton Fertility Centre, Queen Mary University of London, London, UK
Matteo Lambertini MD, PhD IRCCS Policlinico San Martino Hospital, University of Genova, Genova, Italy
Lior Lowenstein MD, MS Rambam Health Care Campus, Haifa, Israel
Liselotte Mettler MD University Hospitals Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
Sanjay Mishra PhD IFTM University, Moradabad, UP, India
Jonathan Tilly PhD Department of Biology, Northeastern University, Boston, MA, USA
Bettina Toth MD Medical University Innsbruck, Innsbruck, Austria
Hans Verstraelen MD, MPH, PhD Ghent University, Belgium
Editorial Review Board
Rotrease Regan, PhD, MPH, WHNP-BC Emory University, Atlanta, USA
Engin Turkgeldi, MD, MSc Koc University, Istanbul, Turkey
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • PubMed Central (PMC)

Manuscript submission guidelines can be accessed on Sage Journals.